ArticleInternational journal of experimental pathology2021

Ixazomib, an oral proteasome inhibitor, exhibits potential effect in dystrophin-deficient mdx mice.

Maria Laura Jorge Micheletto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.